000 | 01546 a2200421 4500 | ||
---|---|---|---|
005 | 20250515234731.0 | ||
264 | 0 | _c20101228 | |
008 | 201012s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2010.07.090 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShi, Lei | |
245 | 0 | 0 |
_aSynthesis and biological activity of flavanone derivatives. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cSep 2010 |
||
300 |
_a5466-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCytoprotection _xdrug effects |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aFlavanones _xchemical synthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
650 | 0 | 4 |
_aMyocytes, Smooth Muscle _xdrug effects |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aFeng, Xiu E | |
700 | 1 | _aCui, Jing Rong | |
700 | 1 | _aFang, Lian Hua | |
700 | 1 | _aDu, Guan Hua | |
700 | 1 | _aLi, Qing Shan | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 20 _gno. 18 _gp. 5466-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2010.07.090 _zAvailable from publisher's website |
999 |
_c20046214 _d20046214 |